SHPH NASDAQ
Shuttle Pharmaceuticals Holdings, Inc.
1W: +1.4%
1M: -16.6%
3M: -6.1%
YTD: +95.0%
1Y: -1.7%
3Y: -97.5%
$3.53
+0.00 (+0.00%)
Weekly Expected Move ±10.7%
$3
$3
$4
$4
$4
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Moderate
50
Insider+$0.2M
Congress—
ETF Holdings—
Key Statistics
Market Cap$2.1M
52W Range2.576-55.9
Volume10,546
Avg Volume2,070,000
Beta1.22
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOChristopher Robert Cooper
Employees2
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2022-08-31
Websiteshuttlepharma.com
401 Professional Drive
Gaithersburg, MD 20879
US
Gaithersburg, MD 20879
US
240 403 4212
About Shuttle Pharmaceuticals Holdings, Inc.
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.
Latest News
12 Health Care Stocks Moving In Wednesday's After-Market Session
12 Health Care Stocks Moving In Monday's After-Market Session
12 Health Care Stocks Moving In Thursday's After-Market Session
12 Health Care Stocks Moving In Thursday's After-Market Session
E.F. Hutton & Co. Serves as Exclusive M&A Advisor and Placement Agent on Completed Shuttle Pharmaceuticals–United Dogecoin Merger to Create the Largest Public Dogecoin Miner
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| HRT FINANCIAL LP | S-Sale | 82,116 | $4.48 | 2026-07-14 |
| HRT FINANCIAL LP | S-Sale | 1,033 | $4.67 | 2026-07-13 |
| HRT FINANCIAL LP | P-Purchase | 731 | $3.11 | 2026-07-10 |
| HRT FINANCIAL LP | 0 | — | 2026-07-09 | |
| HRT FINANCIAL LP | P-Purchase | 8,266 | $3.38 | 2026-07-09 |